Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chinese Journal of New Drugs
1003-3734
2014 Issue 2
bian zhe tui jian
guo chao wei ;
..............page:115
WINDOW OF NEW DRUGS
..............page:123-124
International Pharmacovigilance Flash
ben kan ;
..............page:125-126
Lorcaserin,a new agent for the treatment of obesity
SHI Wei-feng;GUI Cheng;LI Xiao-yu;LIU Gao-lin;Department of Pharmacy;Shanghai Jiao Tong University Affiliated First People’s Hospital;
..............page:127-129+133
Grey clustering analysis for evaluating quality of medicines
CHANG Feng;ZHOU Ying;School of International Pharmaceutical Business;China Pharmaceutical University;
..............page:130-133
Preliminary study on strategy of generics during patent cliff in China
SHEN Tuan-jie;HUANG Tai-kang;Research Center of Modern Social Pharmacy;Shenyang Pharmaceutical University;State Food and Drug Administration;
..............page:134-136+153
Analysis of the factors influencing choice of target vaccines in the expanded program on immunization
DENG Jian-liang;SUN Li-hua;School of Business Administration;Shenyang Pharmaceutical University;
..............page:137-143
Research of Prevention and Treatment of Tumors of Small Nucleic Acids of Chinese Patents
ZHU Ning;Patent Examination Cooperation Center of the Patent Office;
..............page:144-146
General consideration for the nonclinical pharmacodynamic studies of anticancer pharmaceuticals
YAN Li-ping;WANG Hai-xue;WANG Qing-li;Center for Drug Evaluation;China Food and Drug Administration;
..............page:147-148+160
Analysis of chemical constituents with anti-epidermal growth factor receptor activity from Curcuma longa L by UPLC-Q-TOF-MS
WANG Dong-mei;LIN Sen-sen;ZHENG Si-hao;HUANG Lin-fang;Institute of Medicinal Plant Development;Chinese Academy of Medical Science;Peking Union Medical College;New Drug Screening Lab;China Pharmaceutical University;
..............page:149-153
In vitro and in vivo evaluation of pioglitazone hydrochloride/metformin hydrochloride sustained-release tablets
LIN Qiao-ping;LI Wei;SHAN Mang-ting;LIU Chun-hui;XU Xiang-yang;Jiangsu Simcere Pharmaceutical Co.;Ltd.;
..............page:154-160
Research progress of the novel adjuvant CpG ODN
LIU Li;WANG Ju-feng;LI Bo;National Center for Safety Evaluation of Drugs;National Institute for Food and Drug Control;Key Laboratory of Beijing for Nonclinical Safety Evaluation Research of Drugs;National Institute for Food and Drug Control;
..............page:161-170
FDA’s expedite development program for the therapies for serious conditions
DONG Jiang-ping;LI Mao-zhong;YAO Li-xin;SHAO Ying;ZHENG Qiang;Drug Registration Department;China Food and Drug Administration;Center for Pharmaceutical Information and Engineering Research;Peking University;Department of Industrial Engineering and Management;College of Engineering;Peking University;
..............page:171-182+202+183
Clinical research progress of the new antitumor drug lobaplatin in the treatment of small cell lung cancer
LIANG Yu-feng;SUI Dong-hu;CHENG Ying;Department of Medicine;Guizhou Yibai Pharmaceutical Co.;Ltd.;Lung Cancer Medical Center;Jilin Province Tumor Hospital;
..............page:184-188+209
Progress in research of α-glucosidase inhibitors and the structure-activity relationship
WANG Qian;ZHANG Lu;BIAN Xiao-li;WANG Yi-gang;College of Life Science & Engineering;Shanxi University of Science & Technology;Department of Pharmacy;First Affiliated Hospital to Medical College;Xi’an Jiaotong University;School of Medicine;Xi’an Jiaotong University;Clinical Pharmacy Department;215 Hospital of Shanxi Nuclear Geology;
..............page:189-195
Characteristics of the effects of E-4031,terfenadine,cisapride and verapamil on cardiac electrophysiology
LUO Zhuo-ka;LI Xue-hua;LIU Lei;CHEN Ke-su;WANG Zhong-yue;CHEN Long;Department of Pharmacology;College of Pharmacy;Nanjing University of Chinese Medicine;Changzhou Fouth People’s Hospital;Nanjing University Jingling College;Institute of Chinese Medicine of Taizhou China Medical City;
..............page:196-202
Novel self-assembled nano-antimicrobial peptides and antimicrobial peptide drugs
MA Shi-yi;HE Dao-hang;Department of Pharmaceutical Engineering;School of Chemistry and Chemical Engineering;South China University of Technology;
..............page:203-209
Uncertainty evaluation in concentration determination of Rabeprazole in plasma by LC/MS/MS
ZHAO Na-ping;WANG Zhuo;ZHANG Li;GAO Shen;Department of Pharmacy;Changhai Hospital;Second Military Medical University;
..............page:210-214
Efficacy of sitagliptin combined with metformin in the initial treatment of type 2 diabetes with non-alcoholic fatty liver
SONG Xiu-xia;JIANG Tao;KANG Kai;WEN Zhen;Department of Endocrinology;Beijing Shijitan Hospital;Capital Medical University;
..............page:215-218+240
Synthesis and in vitro anti-tumor activities of17-substituted estradiol-pyrimidine derivatives
CHENG Ke-guang;ZHANG Jiang-yu;LIU Guan-yan;CHU Xiang-wu;LING Dan;YAO Guo-yi;State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources;School of Chemistry and Pharmaceutical Sciences;Guangxi Normal University;
..............page:219-225
Synthesis and in vivo efficacy evaluation of NSAIDs-verticinone esters
ZHANG Li;JIANG Yun;LI Zu;WANG Shu;YE Ben-gui;WANG Dong-dong;CHEN Xiong;Department of Pharmacogonosy;West China College of Pharmacy;Sichuan University;State Key Laboratory of Quality Research in Chinese Medicine Institute of Chinese Medical Sciences;University of Macao;
..............page:226-231
Improved synthesis of retigabine
WANG Wei;YANG Jin-lu;ZHANG Yong;College of Chemical and Pharmaceutical Engineering;Hebei University of Science and Technology;State Key Laboratory Breeding Base-Key Laboratory of Molecular Chemistry for Drug of Hebei Province;
..............page:232-234
Pharmacokinetics of icotinib,a novel anti-tumor agent,and its tissue distribution in preclinical species
ZHANG Yi-fan;GUAN Zhong-min;CHEN Xiao-yan;HU Yun-yan;WANG Yin-xiang;ZHONG Da-fang;Shanghai Institute of Materia Medica;Chinese Academy of Sciences;Shenyang Pharmaceutical University;Zhejiang Beta Pharma Inc.;
..............page:235-240
Chiral separation of tirofiban hydrochloride by capillary zone electrophoresis
YIN Yan-jie;ZHANG Bin;ZHANG Qi-ming;Harbin Testing Center for Food and Drug;National Institutes for Food and Drug Control;
..............page:241-243+246
Pharmaceutical care model on chronic disease management
LU Min;CUI Yi-min;BAI Wen-pei;Department of Pharmacy;Peking University First Hospital;Department of Gynecology and Obstetrics;Peking University First Hospital;
..............page:244-246